Alexis Borisy is the founder of EQRx. EQRx has raised $750M in total funding. Latest round: Series B.
Alexis Borisy is the CEO of EQRx, a biotech company focused on developing and selling patent-protected drugs at lower prices than existing medicines. EQRx has raised a total of $750 million, including a $200 million Series A and a $500 million Series B, from investors such as GV, ARCH Venture Partners, and Andreessen Horowitz. Borisy was previously a venture capitalist at Third Rock Ventures.
Full founder directory · Investor directory · Company funding database · Fundraising library